Skip to main content

Table 3 Comparative Data between all 177 ERCP cases. Results are presented as number (%) or median (range) for continuous data

From: LMA® Gastro™ Airway for endoscopic retrograde cholangiopancreatography: a retrospective observational analysis

Characteristics

LMA® Gastro™

Low Flow Nasal cannula

Endotracheal Tube (ETT)

Number of cases (n)

64

85

28

Demographics

 Male/Female

28/36

37/48

10/18

 Age (years)

66 (27–91)

73 (19–95)

78 (18–94)

 Average BMI kg/m2

29 (18–44)

28 (17–44)

29 (18–77)

Nature of ERCP

 Elective

37

52

8

 Emergency

26

35

20

ASA Status 1/2/3/4/5

3/22/32/5/0

17/26/35/7/0

1/3/18/6/1

Airway conversion to ETT

1

1

N/A

Intraoperative SpO2 < 92%

0

1

0

Lowest Intraoperative SpO2

98 (92–100)

98 (89–100)

98 (92–100)

Vasopressor/inotropic/vagolytic use

 Atropine

1

0

1

 Adrenaline

1

0

1

 Ephedrine

0

1

1

 Metaraminol

15

5

9

 Noradrenaline

1

0

3

Mean Duration of Anaesthesia (in minutes)

57

51

71

ERCP Failure

6

2

0

Adverse Intraoperative Eventsa

2

3

0

Adverse 24 h Postoperative (PACU) eventsb

2

1

3

  1. a – adverse events included broncho/laryngospasm, epistaxis, blood-stained secretions and bradycardia
  2. b – adverse events included episodes of laryngospasm, apnoea, minor desaturation (SpO2 < 94%) and abdominal pain